Home > Products > CA19-9 & CD3
> Recombinant Anti-CA19-9 x Anti-CD3 Bispecific Antibody (Fv-IgG)
Recombinant Anti-CA19-9 x Anti-CD3 Bispecific Antibody (Fv-IgG) (CAT#: BSDG-026)
Recombinant Anti-CA19-9 x Anti-CD3 Bispecific Antibody (Fv-IgG) is an appended IgG format, which has 2+2 antigen-binding valency. This dual variable domain IgG is generated by appending variable domains of an anti-CA19-9 IgG with similar domains from an anti-CD3 antibody via short peptide linkers, or vice versa. This BsAb can retarget T cells to tumor cells. It is designed for the research of Ovarian cancer; Pancreatic cancer; Gastric cancer therapy.
There are currently no customer reviews or questions for Recombinant Anti-CA19-9 x Anti-CD3 Bispecific Antibody (Fv-IgG) (BSDG-026). Click the button below to contact us or submit your feedback about this product.